210 related articles for article (PubMed ID: 22807942)
1. Development of novel breast cancer recurrence prediction model using support vector machine.
Kim W; Kim KS; Lee JE; Noh DY; Kim SW; Jung YS; Park MY; Park RW
J Breast Cancer; 2012 Jun; 15(2):230-8. PubMed ID: 22807942
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
4. Nomogram of Naive Bayesian Model for Recurrence Prediction of Breast Cancer.
Kim W; Kim KS; Park RW
Healthc Inform Res; 2016 Apr; 22(2):89-94. PubMed ID: 27200218
[TBL] [Abstract][Full Text] [Related]
5. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
6. A support vector machine model for predicting non-sentinel lymph node status in patients with sentinel lymph node positive breast cancer.
Ding X; Xie S; Chen J; Mo W; Yang H
Tumour Biol; 2013 Jun; 34(3):1547-52. PubMed ID: 23397544
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Oncotype DX, PREDICT and the Nottingham Prognostic Index: Implications for the Management of Early Breast Cancer.
Hillyar C; Rizki H; Abbassi O; Miles-Dua S; Clayton G; Gandamihardja T; Smith S
Cureus; 2020 Apr; 12(4):e7552. PubMed ID: 32382456
[TBL] [Abstract][Full Text] [Related]
9. Firefly-SVM predictive model for breast cancer subgroup classification with clinicopathological parameters.
Sarkar S; Mali K
Digit Health; 2023; 9():20552076231207203. PubMed ID: 37860702
[TBL] [Abstract][Full Text] [Related]
10. Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.
Liu MT; Huang WT; Wang AY; Huang CC; Huang CY; Chang TH; Pi CP; Yang HH
Support Care Cancer; 2010 Dec; 18(12):1553-64. PubMed ID: 19904562
[TBL] [Abstract][Full Text] [Related]
11. A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinoma.
Ni YB; Tsang JY; Chan SK; Tse GM
Ann Surg Oncol; 2014 Sep; 21(9):2928-33. PubMed ID: 24743910
[TBL] [Abstract][Full Text] [Related]
12. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
13. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial.
Schmidt M; Victor A; Bratzel D; Boehm D; Cotarelo C; Lebrecht A; Siggelkow W; Hengstler JG; Elsässer A; Gehrmann M; Lehr HA; Koelbl H; von Minckwitz G; Harbeck N; Thomssen C
Ann Oncol; 2009 Feb; 20(2):258-64. PubMed ID: 18824499
[TBL] [Abstract][Full Text] [Related]
15. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
[TBL] [Abstract][Full Text] [Related]
16. S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.
Malmström P; Bendahl PO; Boiesen P; Brünner N; Idvall I; Fernö M;
J Clin Oncol; 2001 Apr; 19(7):2010-9. PubMed ID: 11283134
[TBL] [Abstract][Full Text] [Related]
17. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning techniques in breast cancer prognosis prediction: A primary evaluation.
Boeri C; Chiappa C; Galli F; De Berardinis V; Bardelli L; Carcano G; Rovera F
Cancer Med; 2020 May; 9(9):3234-3243. PubMed ID: 32154669
[TBL] [Abstract][Full Text] [Related]
19. Research on Early Warning Mechanism and Model of Liver Cancer Rehabilitation Based on CS-SVM.
Jianzhu B; Shuang L; Pengfei M; Yi Z; Yanshu Z
J Healthc Eng; 2021; 2021():6658776. PubMed ID: 33520150
[TBL] [Abstract][Full Text] [Related]
20. The innovative model based on artificial intelligence algorithms to predict recurrence risk of patients with postoperative breast cancer.
Zeng L; Liu L; Chen D; Lu H; Xue Y; Bi H; Yang W
Front Oncol; 2023; 13():1117420. PubMed ID: 36959794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
